Episode Details
Back to EpisodesThe lure of the NASDAQ for Biotechs
Published 3 months, 1 week ago
Description
In this special Flashcast episode of the WTR Small-Cap podcast, Tim Gerdeman and WTR Healthcare analyst Robert Sassoon break down why more than 90% of biotech companies listed on a U.S. exchange choose NASDAQ over the NYSE.